rs1064793734
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001114753.3(ENG):c.1121_1124delAAGA(p.Lys374SerfsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001114753.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.1121_1124delAAGA | p.Lys374SerfsTer6 | frameshift_variant | Exon 8 of 15 | ENST00000373203.9 | NP_001108225.1 | |
ENG | NM_000118.4 | c.1121_1124delAAGA | p.Lys374SerfsTer6 | frameshift_variant | Exon 8 of 14 | NP_000109.1 | ||
ENG | NM_001278138.2 | c.575_578delAAGA | p.Lys192SerfsTer6 | frameshift_variant | Exon 8 of 15 | NP_001265067.1 | ||
ENG | NM_001406715.1 | c.1121_1124delAAGA | p.Lys374SerfsTer5 | frameshift_variant | Exon 8 of 8 | NP_001393644.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.1121_1124delAAGA | p.Lys374SerfsTer6 | frameshift_variant | Exon 8 of 15 | 1 | NM_001114753.3 | ENSP00000362299.4 | ||
ENG | ENST00000344849.4 | c.1121_1124delAAGA | p.Lys374SerfsTer6 | frameshift_variant | Exon 8 of 14 | 1 | ENSP00000341917.3 | |||
ENG | ENST00000480266.6 | c.575_578delAAGA | p.Lys192SerfsTer6 | frameshift_variant | Exon 8 of 15 | 2 | ENSP00000479015.1 | |||
ENG | ENST00000486329.1 | n.89_92delAAGA | non_coding_transcript_exon_variant | Exon 1 of 3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.1121_1124delAAGA deletion in the ENG gene has been reported previously (reported asc.1120_1123 delAAAG due to alternate nomenclature) in one Japanese family with HHT (Dakeishi M etal., 2002). Furthermore, the c.1121_1124delAAGA variant was not observed in approximately 6,500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. This deletion is expected to result in either anabnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNAdecay. Other frameshift variants in the ENG gene have been reported in HGMD in association withHHT (Stenson P et al., 2014). In summary, c.1121_1124delAAGA in the ENG gene is interpreted as a pathogenic variant. -
Hereditary hemorrhagic telangiectasia Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys374Serfs*6) in the ENG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500). This premature translational stop signal has been observed in individuals with hereditary hemorrhagic telangiectasia (PMID: 11793473, 20501893; Invitae). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 419225). This variant is also known as c.1120_1123delAAAG. -
Cardiovascular phenotype Pathogenic:1
The c.1121_1124delAAGA pathogenic mutation, located in coding exon 8 of the ENG gene, results from a deletion of 4 nucleotides between nucleotide positions 1121 and 1124, causing a translational frameshift with a predicted alternate stop codon p.(K374Sfs*6). This mutation was described in an individual meeting clinical diagnostic criteria for HHT (Dakeishi M, Hum. Mutat. 2002 Feb; 19(2):140-8). In addition to the clinical data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at